Part 5 of The Studies Behind Goji
After five articles, the evidence tells a more useful story than a simple claim that goji is "good for your eyes." Human studies have measured how zeaxanthin from goji appears in the blood and how macular pigment measurements changed during specific trials.
The results are interesting. They are also early, varied, and tied to the people and foods that were actually studied.
What human goji research has shown
A 2005 food-based trial followed 27 healthy adults. Fourteen participants ate 15 grams of whole wolfberries daily for 28 days. Fasting plasma zeaxanthin increased in that group, while the matched control group did not show a statistically significant change.
In 2018, 114 adults with early age-related macular degeneration entered a randomized controlled study. Those assigned to 25 grams of goji berries daily for 90 days showed increases in serum zeaxanthin and macular pigment optical density. The paper also reported a change in best corrected visual acuity.
A 2021 randomized pilot trial studied healthy adults aged 45 to 65. Participants ate 28 grams of goji berries five times per week or took a lutein and zeaxanthin supplement for 90 days. The goji group showed increases in macular pigment optical density at two retinal locations and in skin carotenoid scores.
What becomes clearer when the studies sit together
Across these trials, zeaxanthin is the recurring thread. Researchers measured it in blood, examined macular pigment, or did both.
The studies did not use identical designs. They involved healthy adults and adults with early age-related macular degeneration. Serving patterns ranged from 15 grams daily to 28 grams five times per week. Comparison groups also differed.
These differences keep us from treating the papers as one large trial. They do show why the question deserves continued study.
How strong is goji berry research?
The current human evidence supports a careful statement: under the conditions of several small or moderate-sized trials, eating goji berries was associated with changes in serum zeaxanthin and macular pigment measurements.
The evidence does not support a guarantee that goji will improve every person's vision or prevent, treat, or cure an eye disease.
That difference is the central lesson of the series. A measured biological response is meaningful, but it is not the same as a universal clinical outcome.
What researchers still need to answer
Larger studies could test whether findings repeat across different populations. Longer follow-up could show whether measured changes continue. Trials could also compare clearly defined forms of goji while using consistent outcomes.
Those questions matter because whole dried berries, fresh fruit, juice, extracts, and purée are different study materials. Evidence from one format should not be pasted onto another without product-specific research.
The studies in this series also do not replace the guidance developed from large eye-disease trials. The National Eye Institute explains that AREDS2 formulas apply to particular groups of people with age-related macular degeneration. Goji food products are not AREDS2 supplements.
Where goji fits today
Goji can be enjoyed as food. Fresh fruit is soft, juicy, and naturally sweet. Dried berries and purée offer different textures and routines, as described in our guide to fresh and dried goji berries.
The Goji Reserve was created around that food-first view. Our fresh goji purée is made for everyday use, but we do not assume that a study using whole dried berries proves a result for our product.
Readers who want to keep following the evidence can visit our Research page. The standard remains simple: name the study, describe what it measured, and leave its limits attached.
The five-part conclusion
Part 1 asked why goji entered eye research. Part 2 explained zeaxanthin. Part 3 showed how to read a trial, and Part 4 examined the 2018 study.
The conclusion is neither a miracle claim nor a dismissal. Goji contains a pigment that researchers can trace and measure in humans. Early trials give us reasons to keep studying it. They do not turn food into medicine.
References
- Cheng CY, Chung WY, Szeto YT, Benzie IFF. Fasting plasma zeaxanthin response to Fructus barbarum L. (wolfberry; Kei Tze) in a food-based human supplementation trial. British Journal of Nutrition. 2005;93(1):123-130. DOI: 10.1079/BJN20041284. PMID: 15705234.
- Li S, Liu N, Lin L, Sun ED, Li JD, Li PK. Macular pigment and serum zeaxanthin levels with Goji berry supplement in early age-related macular degeneration. International Journal of Ophthalmology. 2018;11(6):970-975. PMID: 29977809.
- Li X, Holt RR, Keen CL, Morse LS, Yiu G, Hackman RM. Goji Berry Intake Increases Macular Pigment Optical Density in Healthy Adults: A Randomized Pilot Trial. Nutrients. 2021;13(12):4409. DOI: 10.3390/nu13124409. PMID: 34959963.
- National Eye Institute. AREDS/AREDS2 Frequently Asked Questions. Updated November 19, 2020.
This article is for general educational purposes and is not medical advice. A food product should not be used in place of diagnosis or treatment from a qualified eye care professional.